A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

February 25, 2013

Primary Completion Date

November 2, 2016

Study Completion Date

July 13, 2017

Conditions
Chronic Hepatitis C Infection
Interventions
DRUG

ombitasvir/paritaprevir/ritonavir and dasabuvir

Tablet; ombitasvir coformulated with paritaprevir and ritonavir, dasabuvir tablet

DRUG

ombitasvir/paritaprevir/ritonavir

Tablet; ombitasvir coformulated with paritaprevir and ritonavir

DRUG

ribavirin

tablet

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY